Penguin Good News | Congratulations on the Partnership Between Weiming Penguin and China Resources Sanjiu!
Article images may contain Chinese text.
Recently, Shenzhen China Resources Sanjiu Pharmaceutical Trading Co., Ltd. formed a partnership with Weiming Penguin. Weiming Penguin will help China Resources Sanjiu’s business departments manage effective sales activities, supporting process-driven, standardized, online operations and improving operating efficiency.

About China Resources Sanjiu
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (“China Resources Sanjiu”) is a large, state-controlled, publicly listed pharmaceutical company, primarily engaged in the research and development, production, and sale of pharmaceutical products and related healthcare services. Since its listing, the company has repeatedly been named among the “Golden Bull Top 100” and “Top 100 by Value” companies listed on China’s main stock market boards. China Resources Sanjiu’s core businesses focus on CHC consumer healthcare products and prescription medicines, spanning nearly 10 categories, including cold remedies, dermatology, gastrointestinal treatments, cough remedies, orthopedics, and pediatrics. Its prescription medicine business focuses on therapeutic areas including oncology, cardiovascular and cerebrovascular diseases, gastrointestinal diseases, orthopedics, and pediatrics. Against a continually changing pharmaceutical industry backdrop, China Resources Sanjiu pursues “high-quality development” through innovation, using both brand strength and innovation as its twin engines. Through ongoing innovative transformation and upgrading, it is committed to becoming a leader in the pharmaceutical and healthcare industry serving the public.
About Weiming Penguin
Weiming Penguin is a technology company dedicated to empowering the digital transformation of pharmaceutical marketing. Its management systems are designed to be secure, stable, timely, accurate, lightweight, and highly compatible. Through digital marketing tools and customized data services tailored to each company’s business characteristics, it upgrades business models, pushes the boundaries of efficiency, and helps the pharmaceutical industry pursue standardized management, improve efficiency, build data assets, and achieve value-driven growth.
